CrowdJustice Raises $2M in Seed Funding
CrowdJustice, a London/NYC-based legal crowdfunding platform, secured $2m in seed funding.
CrowdJustice, a London/NYC-based legal crowdfunding platform, secured $2m in seed funding.
NetGuardians SA, an Yverdon-les-Bains, Switzerland-based fintech fraud prevention and risk mitigation platform provider, raised CHF8.5m in Series C funding.
Data Inventions, a Cincinnati, OH-based technology company focused on innovating conventional manufacturing, raised a funding round of undisclosed amount.
HelloMD, a San Francisco, CA-based community of medical cannabis patients, raised $200k in funding.
In light of recent catastrophes, cyber security is a hot topic and each day the industry grows larger and more dramatic.
Nivesh.com, a Noida, Uttar Pradesh, India-based innovative mass market mutual funds investment platform targeting mainly the highly potential markets in the tier 2 and 3 cities of India, raised an angel funding of undisclosed amount.
Evolve BioSystems, Inc., a Davis, CA-based microbiome company committed to developing novel solutions to restore and maintain a healthy newborn gut microbiome, completed a $20m Series B funding.
Playsnak, a Los Angeles, CA- and Berlin, Germany-based virtual reality gaming startup, secured $1.2m in seed funding.
People.ai, a San Francisco, CA-based maker of a predictive sales management platform, raised $7m in Series A funding.
CounterTack, a Waltham, MA-based provider of an Endpoint Threat Platform (ETP) for the enterprise, raised $20m in Series D funding.
Epic!, a Redwood City, CA-based digital brand for kids, raised $8m in Series C funding.
Wave, a Toronto, CA-based provider of financial management software for entrepreneurs and small business owners, raised US$24m in funding.
Meditrix, a Tokyo, Japan-based Contract Research Organization (CRO), received an investment from genae, a CRO and service provider for the medical industries.
AB Tasty, a Paris, France-based developer of user testing, user experience and personalization platform, raised $17m in Series B funding.
Venture capital firm Frazier Healthcare Partners has added Chris Peetz to the Life Sciences team as an Entrepreneur-in-Residence (EIR).